Abstract 5775: Identification of SAR439859, an orally bioavailable selective estrogen receptor degrader (SERD) that has strong anti-tumor activity in wild-type and mutant ER+ breast cancer models Maysoun Shomali , Youssef El-Ahmad , Frank Halley , Jane Cheng , Michael Weinstein , Muchun Wang , Fangxian Sun , Natalia Malkova , Mikhail Levit , Malvika Koundinya , Zhuyan Gou , Andrew Hebert , Jessica McManus , Dietmar Hoffman , Hui Cao , Joonil Jung , Jack Pollard , Sylvie Vincent , Timothy Ackerson , Francisco Adrian , Chris Winter , Victoria Richon , Hong Chen , Karl Hsu , Joanne Lager , Albane Courjaud , Rosalia Arrebola , Laurent Besret , Pierre-Yves Abecassis , Laurent Schio , Gary McCort , Michel Tabart , Victor Certal , Fabienne Thompson , Bruno Filoche-Rommé , Laurent Debussche , Patrick Cohen , Carlos Garcia-Echeverria , Monsif Bouaboula Experimental and Molecular Therapeutics（2018）
AI 理解论文
溯源树
样例
